Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.747,29
0,03%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SeaStar Medical Holding Corporation (ICU) SeaStar Medical Holding Corporation (ICU) Notizie

ICU

SeaStar Medical (ICU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ICU
DataOraFonteTitoloSimboloCompagnia
22/05/202414:30GlobeNewswire Inc.Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant EligibilityNASDAQ:ICUSeaStar Medical Holding Corporation
14/05/202422:05GlobeNewswire Inc.SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
30/04/202414:30GlobeNewswire Inc.SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
17/04/202422:00GlobeNewswire Inc.SeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
11/04/202414:30GlobeNewswire Inc.SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
27/03/202413:30GlobeNewswire Inc.SeaStar Medical to Restate Financials, Sets Business Update Call for April 17NASDAQ:ICUSeaStar Medical Holding Corporation
12/03/202413:30GlobeNewswire Inc.SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
11/03/202421:05GlobeNewswire Inc.SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024NASDAQ:ICUSeaStar Medical Holding Corporation
27/02/202414:30GlobeNewswire Inc.Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
22/02/202413:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:ICUSeaStar Medical Holding Corporation
22/02/202413:53GlobeNewswire Inc.FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
01/02/202414:30GlobeNewswire Inc.SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device TechnologyNASDAQ:ICUSeaStar Medical Holding Corporation
26/01/202414:05GlobeNewswire Inc.SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-MarketNASDAQ:ICUSeaStar Medical Holding Corporation
11/01/202422:05GlobeNewswire Inc.SeaStar Medical Appoints David A. Green as Chief Financial OfficerNASDAQ:ICUSeaStar Medical Holding Corporation
09/01/202414:30GlobeNewswire Inc.SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical IndicationsNASDAQ:ICUSeaStar Medical Holding Corporation
28/12/202314:30GlobeNewswire Inc.SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
13/12/202314:30GlobeNewswire Inc.SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical ExpertsNASDAQ:ICUSeaStar Medical Holding Corporation
14/11/202322:04GlobeNewswire Inc.SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
31/10/202313:00GlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:ICUSeaStar Medical Holding Corporation
30/10/202313:00GlobeNewswire Inc.FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
18/10/202314:30GlobeNewswire Inc.FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
05/10/202314:30GlobeNewswire Inc.SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023NASDAQ:ICUSeaStar Medical Holding Corporation
03/10/202322:05GlobeNewswire Inc.SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionNASDAQ:ICUSeaStar Medical Holding Corporation
29/09/202314:30GlobeNewswire Inc.FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
21/09/202315:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
30/08/202322:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICUSeaStar Medical Holding Corporation
29/08/202314:00GlobeNewswire Inc.Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood PurificationNASDAQ:ICUSeaStar Medical Holding Corporation
22/08/202314:00GlobeNewswire Inc.SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern TimeNASDAQ:ICUSeaStar Medical Holding Corporation
17/08/202323:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICUSeaStar Medical Holding Corporation
15/08/202322:45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ICUSeaStar Medical Holding Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ICU

La tua Cronologia

LSE
100H
Am Ftse100 Usdh
EU
BNR8B
Bnp Paribas null
COIN
ICXUST
ICON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network